Chronological Analysis of First-in-Class Drugs Approved from 2011 to 2022: Their Technological Trend and Origin

The discovery and development of first-in-class (FIC) drugs are becoming increasingly important due to increasing reimbursement pressure and personalized medication. To investigate the technological trends and origin of FIC drugs, the FIC drugs approved in the U.S. from January 2011 to December 2022...

Descripción completa

Detalles Bibliográficos
Autor principal: Okuyama, Ryo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386398/
https://www.ncbi.nlm.nih.gov/pubmed/37513981
http://dx.doi.org/10.3390/pharmaceutics15071794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386398/
https://www.ncbi.nlm.nih.gov/pubmed/37513981
http://dx.doi.org/10.3390/pharmaceutics15071794

Ejemplares similares